ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1

Q4 2024 13F Holders as of 12/31/2024

Type / Class
Debt / NOTE 4.000%11/1
Number of holders
6
Total 13F principal, excl. options
33.2M
Principal change
-133M
Total reported value, excl. options
$32.2M
Value change
-$171M
Number of sells
-10
Price
$0.97

Significant Holders of ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 as of Q4 2024

15 filings reported holding 29664WAB1 - ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 as of Q4 2024.
ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 has 6 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of $33.2M of principal .
Largest 10 bondholders include Pentwater Capital Management LP ($10.9M of principal), Whitefort Capital Management, LP ($8M of principal), AMERIPRISE FINANCIAL INC ($6M of principal), Two Seas Capital LP ($5.32M of principal), Jefferies Financial Group Inc. ($2.7M of principal), ZAZOVE ASSOCIATES LLC ($375K of principal), DeepCurrents Investment Group LLC ($0 of principal), WHITEBOX ADVISORS LLC ($0 of principal), Context Capital Management, LLC ($0 of principal), and BlackRock, Inc. ($0 of principal).
This table shows the top 6 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.